BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in bl
BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker Corp - disqver acquisition not expected to be material to Bruker fy26 results - Financial details of transaction were not disclosed
BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker Corp - disqver acquisition not expected to be material to Bruker fy26 results - Financial details of transaction were not disclosed